Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Net Profit Margin: 13.20%

Is Medtronic plc’s net profit margin high or low?

Medtronic plc's net profit margin of 13.20% is in line with its 5-year average of 13.06%, around the middle of its 5-year range (11.36%–15.90%).

The net profit margin for Medtronic plc (MDT) is 13.20% as of Wednesday, June 10, 2026. It is below its 12-month average by 2.58% (13.55%).

MDT Net Profit Margin Chart

MDT Net Profit Margin
13.20%-5.04% 1Y
Zoom

MDT Average Net Profit Margin Chart

MDT Current vs Average Net Profit Margin Chart

MDT Net Profit Margin Metrics

NET PROFIT MARGIN

13.20%

NET PROFIT MARGIN AVG TTM

13.55%

NET PROFIT MARGIN AVG 3Y

12.62%

NET PROFIT MARGIN AVG 5Y

13.06%

NET PROFIT MARGIN AVG 10Y

13.30%

NET PROFIT MARGIN AVG 15Y

15.01%

NET PROFIT MARGIN AVG 20Y

16.02%

CURRENT VS TTM AVG

-2.58%

CURRENT VS 3Y AVG

+4.58%

CURRENT VS 5Y AVG

+1.07%

CURRENT VS 10Y AVG

-0.73%

CURRENT VS 15Y AVG

-12.06%

CURRENT VS 20Y AVG

-17.61%

MDT Competitors' Net Profit Margin

NAMEMARKET CAPNET PROFIT MARGINTTM3Y5Y
Medtronic plc (MDT)$103.04B13.20%13.55%12.62%13.06%
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B35.40%13.94%25.44%29.40%
Bristol-Myers Squibb Company (BMY)$114.14B15.01%-1.95%6.91%3.59%
Elevance Health Inc. (ELV)$87.43B2.62%3.11%3.37%3.60%
CVS Health Corporation (CVS)$125.16B0.72%0.84%1.34%1.79%
Cigna Corporation (CI)$78.25B2.26%1.78%2.48%3.04%
Danaher Corporation (DHR)$130.25B14.89%15.52%19.51%19.37%
Regeneron Pharmaceuticals, Inc. (REGN)$62.59B29.65%31.24%32.06%36.64%
Pfizer Inc. (PFE)$146.36B11.83%12.51%14.97%18.18%
Intuitive Surgical, Inc. (ISRG)$146.44B28.15%28.09%25.67%26.14%

Margin Comparison

Operating Margin

17.8%

Net Profit Margin

13.2%

Medtronic plc Net Profit Margin Formula & Definition

Net Profit Margin = Net Income / Revenue

Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Net Profit Margin FAQ

What is the net profit margin for Medtronic plc (MDT)?
The net profit margin for MDT stock is 13.20%.
Is Medtronic plc's net profit margin high or low?
Medtronic plc's net profit margin of 13.20% is in line with its 5-year average of 13.06%, around the middle of its 5-year range (11.36%–15.90%).
What is the TTM average net profit margin for Medtronic plc (MDT)?
The TTM average net profit margin for MDT stock is 13.55%.
What is the 3Y average net profit margin for Medtronic plc (MDT)?
The 3Y average net profit margin for MDT stock is 12.62%.
What is the 5Y average net profit margin for Medtronic plc (MDT)?
The 5Y average net profit margin for MDT stock is 13.06%.
What is the 10Y average net profit margin for Medtronic plc (MDT)?
The 10Y average net profit margin for MDT stock is 13.30%.
What is the 15Y average net profit margin for Medtronic plc (MDT)?
The 15Y average net profit margin for MDT stock is 15.01%.
What is the 20Y average net profit margin for Medtronic plc (MDT)?
The 20Y average net profit margin for MDT stock is 16.02%.

Medtronic plc Net Profit Margin History

DATENET PROFIT MARGIN
2026-04-2413.20%
2025-04-2513.90%
2024-04-2611.36%
2023-04-2812.03%
2022-04-2915.90%
2021-04-3011.97%
2020-04-2416.56%
2019-04-3015.16%
2018-04-3010.36%
2017-04-3013.56%
2016-04-3012.27%
2015-04-3013.20%
2014-04-3018.02%
2013-04-3020.90%
2012-04-3022.35%
2011-04-3019.43%
2010-04-3019.59%
2009-04-3014.86%
2008-04-3016.51%
2007-04-3022.78%
2006-04-3022.55%
2005-04-3017.94%
2004-04-3021.56%
2003-04-3020.87%
2002-04-3015.35%
2001-04-3018.84%
2000-04-3021.91%
1999-04-3011.33%
1998-04-3022.83%
1997-04-3023.92%

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha